Advertisement

HARBIN, China, May 13 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that Mr. Stanley Hao, the Company's Chief Financial Officer, will participate in the following investor conferences in May 2010.

CCG China Rising Investment Conference Time: Monday, May 17, 2010 Presentation: 4:00 pm ET Location: Grand Hyatt New York, 109 East 42nd Street, New York Brean Murray, Carret & Co. 2010 Life Sciences Summit Time: Monday, May 17, 2010 Location: Grand Hyatt New York, 109 East 42nd Street, New York Oppenheimer China Dragon Call Conference Time: May 18, 2010 Presentation: 10:00 am ET Location: 300 Madison Avenue, 3rd Floor, New York

Management will be available for one-on-one meetings with investors at the conferences. Please contact the respective representatives for each conference to set up the meetings.

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First

'/>"/>

SOURCE

Advertisement
Advertisement